Global Immuno-oncology Drugs Market Insights, Forecast to 2025

Global Immuno-oncology Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Immuno-oncology Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Immuno-oncology Drugs Market Size Growth Rate by Product
1.4.2 Immune Checkpoint Inhibitors
1.4.3 Monoclonal Antibodies
1.4.4 Cytokine-Based Immunotherapy
1.4.5 Cancer Vaccines
1.4.6 CAR-T Cell Therapy
1.5 Market by End User
1.5.1 Global Immuno-oncology Drugs Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Immuno-oncology Drugs Market Size
2.1.1 Global Immuno-oncology Drugs Revenue 2014-2025
2.1.2 Global Immuno-oncology Drugs Sales 2014-2025
2.2 Immuno-oncology Drugs Growth Rate by Regions
2.2.1 Global Immuno-oncology Drugs Sales by Regions
2.2.2 Global Immuno-oncology Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Immuno-oncology Drugs Sales by Manufacturers
3.1.1 Immuno-oncology Drugs Sales by Manufacturers
3.1.2 Immuno-oncology Drugs Sales Market Share by Manufacturers
3.1.3 Global Immuno-oncology Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Immuno-oncology Drugs Revenue by Manufacturers
3.2.1 Immuno-oncology Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Immuno-oncology Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Immuno-oncology Drugs Price by Manufacturers
3.4 Immuno-oncology Drugs Manufacturing Base Distribution, Product Types
3.4.1 Immuno-oncology Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immuno-oncology Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Immuno-oncology Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Immuno-oncology Drugs Sales by Product
4.2 Global Immuno-oncology Drugs Revenue by Product
4.3 Immuno-oncology Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Immuno-oncology Drugs Breakdown Data by End User
6 North America
6.1 North America Immuno-oncology Drugs by Countries
6.1.1 North America Immuno-oncology Drugs Sales by Countries
6.1.2 North America Immuno-oncology Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Immuno-oncology Drugs by Product
6.3 North America Immuno-oncology Drugs by End User
7 Europe
7.1 Europe Immuno-oncology Drugs by Countries
7.1.1 Europe Immuno-oncology Drugs Sales by Countries
7.1.2 Europe Immuno-oncology Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Immuno-oncology Drugs by Product
7.3 Europe Immuno-oncology Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Immuno-oncology Drugs by Countries
8.1.1 Asia Pacific Immuno-oncology Drugs Sales by Countries
8.1.2 Asia Pacific Immuno-oncology Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Immuno-oncology Drugs by Product
8.3 Asia Pacific Immuno-oncology Drugs by End User
9 Central & South America
9.1 Central & South America Immuno-oncology Drugs by Countries
9.1.1 Central & South America Immuno-oncology Drugs Sales by Countries
9.1.2 Central & South America Immuno-oncology Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Immuno-oncology Drugs by Product
9.3 Central & South America Immuno-oncology Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Immuno-oncology Drugs by Countries
10.1.1 Middle East and Africa Immuno-oncology Drugs Sales by Countries
10.1.2 Middle East and Africa Immuno-oncology Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Immuno-oncology Drugs by Product
10.3 Middle East and Africa Immuno-oncology Drugs by End User
11 Company Profiles
11.1 Amgen, Inc
11.1.1 Amgen, Inc Company Details
11.1.2 Company Business Overview
11.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Amgen, Inc Immuno-oncology Drugs Products Offered
11.1.5 Amgen, Inc Recent Development
11.2 AstraZeneca, Plc
11.2.1 AstraZeneca, Plc Company Details
11.2.2 Company Business Overview
11.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 AstraZeneca, Plc Immuno-oncology Drugs Products Offered
11.2.5 AstraZeneca, Plc Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Company Business Overview
11.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bristol-Myers Squibb Immuno-oncology Drugs Products Offered
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Details
11.4.2 Company Business Overview
11.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Celgene Corporation Immuno-oncology Drugs Products Offered
11.4.5 Celgene Corporation Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Company Business Overview
11.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Eli Lilly and Company Immuno-oncology Drugs Products Offered
11.5.5 Eli Lilly and Company Recent Development
11.6 Merck & Co.
11.6.1 Merck & Co. Company Details
11.6.2 Company Business Overview
11.6.3 Merck & Co. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Merck & Co. Immuno-oncology Drugs Products Offered
11.6.5 Merck & Co. Recent Development
11.7 Hoffmann-La Roche AG
11.7.1 Hoffmann-La Roche AG Company Details
11.7.2 Company Business Overview
11.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Hoffmann-La Roche AG Immuno-oncology Drugs Products Offered
11.7.5 Hoffmann-La Roche AG Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Company Business Overview
11.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Johnson & Johnson Immuno-oncology Drugs Products Offered
11.8.5 Johnson & Johnson Recent Development
11.9 Novartis International AG
11.9.1 Novartis International AG Company Details
11.9.2 Company Business Overview
11.9.3 Novartis International AG Immuno-oncology Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Novartis International AG Immuno-oncology Drugs Products Offered
11.9.5 Novartis International AG Recent Development
11.10 AbbVie, Inc.
11.10.1 AbbVie, Inc. Company Details
11.10.2 Company Business Overview
11.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 AbbVie, Inc. Immuno-oncology Drugs Products Offered
11.10.5 AbbVie, Inc. Recent Development
11.11 Pfizer Inc.
11.12 Sanofi S.A.
11.13 EMD Serono, Inc.
11.14 Gilead Sciences Inc.
11.15 Prometheus Therapeutics & Diagnostics
11.16 Aduro BioTech
11.17 Galena Biopharma
11.18 Bavarian Nordic
11.19 Celldex Therapeutics
11.20 ImmunoCellular Therapeutics
11.21 Incyte
12 Future Forecast
12.1 Immuno-oncology Drugs Market Forecast by Regions
12.1.1 Global Immuno-oncology Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Immuno-oncology Drugs Revenue Forecast by Regions 2019-2025
12.2 Immuno-oncology Drugs Market Forecast by Product
12.2.1 Global Immuno-oncology Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Immuno-oncology Drugs Revenue Forecast by Product 2019-2025
12.3 Immuno-oncology Drugs Market Forecast by End User
12.4 North America Immuno-oncology Drugs Forecast
12.5 Europe Immuno-oncology Drugs Forecast
12.6 Asia Pacific Immuno-oncology Drugs Forecast
12.7 Central & South America Immuno-oncology Drugs Forecast
12.8 Middle East and Africa Immuno-oncology Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immuno-oncology Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Immuno-oncology Drugs Product Picture
Table Immuno-oncology Drugs Market Segments
Table Key Manufacturers Immuno-oncology Drugs Covered
Table Global Immuno-oncology Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Immuno-oncology Drugs Sales Market Share by Product 2014-2025
Figure Immune Checkpoint Inhibitors Product Picture
Table Major Manufacturers of Immune Checkpoint Inhibitors
Figure Monoclonal Antibodies Product Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Cytokine-Based Immunotherapy Product Picture
Table Major Manufacturers of Cytokine-Based Immunotherapy
Figure Cancer Vaccines Product Picture
Table Major Manufacturers of Cancer Vaccines
Figure CAR-T Cell Therapy Product Picture
Table Major Manufacturers of CAR-T Cell Therapy
Table Global Immuno-oncology Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Pharmacies
Figure Online Pharmacies
Figure Immuno-oncology Drugs Report Years Considered
Figure Global Immuno-oncology Drugs Market Size 2014-2025 (Million US$)
Figure Global Immuno-oncology Drugs Sales 2014-2025 (K Units)
Table Global Immuno-oncology Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Immuno-oncology Drugs Sales by Regions 2014-2019 (K Units)
Table Global Immuno-oncology Drugs Sales Market Share by Regions 2014-2019
Figure Global Immuno-oncology Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Immuno-oncology Drugs Sales Market Share by Regions
Table Global Immuno-oncology Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Immuno-oncology Drugs Revenue Market Share by Regions 2014-2019
Figure Global Immuno-oncology Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Immuno-oncology Drugs Revenue Market Share by Regions
Table Global Immuno-oncology Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Immuno-oncology Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Immuno-oncology Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Immuno-oncology Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Immuno-oncology Drugs Revenue Share by Manufacturers (2014-2019)
Figure Immuno-oncology Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Immuno-oncology Drugs Price (2014-2019) (USD/Unit)
Table Immuno-oncology Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Immuno-oncology Drugs Product Type
Table Date of International Manufacturers Enter into Immuno-oncology Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Immuno-oncology Drugs Sales by Product (2014-2019) (K Units)
Table Global Immuno-oncology Drugs Sales Share by Product (2014-2019)
Figure Global Immuno-oncology Drugs Sales Market Share by Product (2014-2019)
Figure Global Immuno-oncology Drugs Sales Market Share by Product in 2018
Table Global Immuno-oncology Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Immuno-oncology Drugs Revenue Share by Product (2014-2019)
Figure Global Immuno-oncology Drugs Revenue Market Share by Product (2014-2019)
Figure Global Immuno-oncology Drugs Revenue Market Share by Product in 2018
Table Immuno-oncology Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Immuno-oncology Drugs Sales by End User (2014-2019) (K Units)
Table Global Immuno-oncology Drugs Sales Share by End User (2014-2019)
Figure Global Sales Immuno-oncology Drugs Market Share by End User (2014-2019)
Figure Global Sales Immuno-oncology Drugs Market Share by End User in 2018
Figure North America Immuno-oncology Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Immuno-oncology Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Immuno-oncology Drugs Sales by Countries (2014-2019) (K Units)
Table North America Immuno-oncology Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Immuno-oncology Drugs Sales Market Share by Countries
Table North America Immuno-oncology Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Immuno-oncology Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Immuno-oncology Drugs Revenue Market Share by Countries
Figure United States Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Immuno-oncology Drugs Sales by Product (2014-2019) (K Units)
Table North America Immuno-oncology Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Immuno-oncology Drugs Market Share by Product
Table North America Immuno-oncology Drugs Sales by End User (2014-2019) (K Units)
Table North America Immuno-oncology Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Immuno-oncology Drugs Market Share by End User
Figure Europe Immuno-oncology Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Immuno-oncology Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Immuno-oncology Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Immuno-oncology Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Immuno-oncology Drugs Sales Market Share by Countries
Table Europe Immuno-oncology Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Immuno-oncology Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Immuno-oncology Drugs Revenue Market Share by Countries
Figure Germany Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Immuno-oncology Drugs Sales by Product (2014-2019) (K Units)
Table Europe Immuno-oncology Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Immuno-oncology Drugs Market Share by Product
Table Europe Immuno-oncology Drugs Sales by End User (2014-2019) (K Units)
Table Europe Immuno-oncology Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Immuno-oncology Drugs Market Share by End User
Figure Asia Pacific Immuno-oncology Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Immuno-oncology Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Immuno-oncology Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Immuno-oncology Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Immuno-oncology Drugs Sales Market Share by Countries
Table Asia Pacific Immuno-oncology Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Immuno-oncology Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Immuno-oncology Drugs Revenue Market Share by Countries
Figure China Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Immuno-oncology Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Immuno-oncology Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Immuno-oncology Drugs Market Share by Product
Table Asia Pacific Immuno-oncology Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Immuno-oncology Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Immuno-oncology Drugs Market Share by End User
Figure Central & South America Immuno-oncology Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Immuno-oncology Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Immuno-oncology Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Immuno-oncology Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Immuno-oncology Drugs Sales Market Share by Countries
Table Central & South America Immuno-oncology Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Immuno-oncology Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Immuno-oncology Drugs Revenue Market Share by Countries
Figure Brazil Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Immuno-oncology Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Immuno-oncology Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Immuno-oncology Drugs Market Share by Product
Table Central & South America Immuno-oncology Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Immuno-oncology Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Immuno-oncology Drugs Market Share by End User
Figure Middle East and Africa Immuno-oncology Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Immuno-oncology Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Immuno-oncology Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Immuno-oncology Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Immuno-oncology Drugs Sales Market Share by Countries
Table Middle East and Africa Immuno-oncology Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Countries
Figure GCC Countries Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Immuno-oncology Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Immuno-oncology Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Immuno-oncology Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Immuno-oncology Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Immuno-oncology Drugs Market Share by Product
Table Middle East and Africa Immuno-oncology Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Immuno-oncology Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Immuno-oncology Drugs Market Share by End User
Table Amgen, Inc Company Details
Table Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen, Inc Recent Development
Table AstraZeneca, Plc Company Details
Table AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca, Plc Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Celgene Corporation Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly and Company Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co. Recent Development
Table Hoffmann-La Roche AG Company Details
Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Hoffmann-La Roche AG Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Novartis International AG Company Details
Table Novartis International AG Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis International AG Recent Development
Table AbbVie, Inc. Company Details
Table AbbVie, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie, Inc. Recent Development
Table Pfizer Inc. Company Details
Table Sanofi S.A. Company Details
Table EMD Serono, Inc. Company Details
Table Gilead Sciences Inc. Company Details
Table Prometheus Therapeutics & Diagnostics Company Details
Table Aduro BioTech Company Details
Table Galena Biopharma Company Details
Table Bavarian Nordic Company Details
Table Celldex Therapeutics Company Details
Table ImmunoCellular Therapeutics Company Details
Table Incyte Company Details
Table Global Immuno-oncology Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Immuno-oncology Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Immuno-oncology Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Immuno-oncology Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Immuno-oncology Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Immuno-oncology Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Immuno-oncology Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Immuno-oncology Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Immuno-oncology Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Immuno-oncology Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Immuno-oncology Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Immuno-oncology Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Immuno-oncology Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Immuno-oncology Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Immuno-oncology Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Immuno-oncology Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Immuno-oncology Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Immuno-oncology Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Immuno-oncology Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Immuno-oncology Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Immuno-oncology Drugs Value Chain
Table Immuno-oncology Drugs Customers List
Table Immuno-oncology Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs